Winship Cancer Institute - Emory University
Seeing over 17,000 patients a year, Winship Cancer Institute of Emory University is Georgia's only National Cancer Institute-designated comprehensive cancer center and serves as the coordinating center for cancer research, education and care throughout Emory University.
Videos
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"
FEATURING
Nabil Saba
- 732 views
- June 13, 2024
- 4
Winship Cancer Institute - Emory University
Updates on Myeloproliferative Neoplasms Including CML
FEATURING
Anthony Hunter
- 112 views
- May 7, 2024
Winship Cancer Institute - Emory University
Multiple Myeloma: Clinical Challenges for the Community Clinician
FEATURING
Nisha Joseph
- 242 views
- April 16, 2024
- 3
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Standard- and High-Risk ND Transplant-Eligible MM Pts Treated With RVD vs. Dara-RVD"
FEATURING
Nisha Joseph
- 454 views
- December 22, 2023
- 1
Winship Cancer Institute - Emory University
Case Studies of a Patient With HR+/HER2- mBC: Treatment Approach in Later Lines of Treatment
FEATURING
Demetria Smith-Graziani
- 202 views
- December 13, 2023
- 3
Oncology Data Advisor
ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, & Tolerability of Sacituzumab Govitecan for 2L & Later Treatment of mTNBC"
FEATURING
Kevin Kalinsky
- 1,028 views
- November 7, 2023
- 2
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Choosing and Properly Using a JAK Inhibitor in Myelofibrosis
FEATURING
Anthony Hunter
- 79 views
- October 16, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 DEBATE: Smoldering MM - Personalized Time to Treat?
FEATURING
Sagar Lonial
- 71 views
- October 12, 2023
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
FEATURING
Anthony Hunter
- 269 views
- September 29, 2023
Winship Cancer Institute - Emory University
Harnessing IO in the Management of CSCC
FEATURING
Nabil Saba
- 95 views
- September 21, 2023
- 2
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "2L High-Dose Chemotherapy in Refractory/Recurrent NSGCT Patients"
FEATURING
Edmund Waller
- 97 views
- June 29, 2023
- 3
Insights from 2023 ASCO® Annual Meeting
Immunotherapy Trials for Nasopharyngeal Cancers
FEATURING
Nabil Saba
- 384 views
- June 16, 2023
- 3
ecancer
ASCO® 2023 Insights: "Elranatamab in Patients With R/R MM Previously Exposed to BCMA-Directed Therapies"
FEATURING
Ajay Nooka
- 24 views
- June 14, 2023
ecancer
ASCO® 2023 Insights: "Phase 3 LUNAR Study - Tumor Treating Fields Therapy for mNSCLC After Platinum Failure"
FEATURING
Ticiana Leal
- 234 views
- June 14, 2023
- 1
Winship Cancer Institute - Emory University
The Promise of Oral SERDs for Breast Cancer: Brief Review/Update
FEATURING
Manali Bhave
- 56 views
- May 11, 2023
Winship Cancer Institute - Emory University
Optimising Chemoradiation to Reduce Pneumonitis Risk in Patients With Locally Advanced NSCLC
FEATURING
Neal McCall
- 168 views
- March 1, 2023
- 2
Winship Cancer Institute - Emory University
Defining and Identifying HER2-Low Breast Cancer
FEATURING
Jane Meisel
- 265 views
- February 23, 2023
- 2
Winship Cancer Institute - Emory University
Desmoid Fibromatosis: An Update on Current State of Treatment
FEATURING
Kenneth Cardona
- 175 views
- December 15, 2022
- 1
Winship Cancer Institute - Emory University
Lecture Summary - TP53 Screening in HR-MDS and Its Role in Treatment Selection
FEATURING
Anthony Hunter
- 4 views
- September 14, 2022
Winship Cancer Institute - Emory University
TP53 Screening in HR-MDS and Its Role in Treatment Selection
FEATURING
Anthony Hunter
- 189 views
- September 14, 2022
- 2
Winship Cancer Institute - Emory University
Daratumumab With Pomalidomide & Dexamethasone at 1st Relapse in R/R MM Patients
FEATURING
Nisha Joseph
- 227 views
- April 13, 2022
- 1
Winship Cancer Institute - Emory University
ASCO 2021 Updates on Preoperative Therapy in BC: Why Surgery Is Not Always First
FEATURING
Kevin Kalinsky
- 590 views
- June 29, 2021
- 3